Ads
related to: pfizer vaccine
Search results
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 48 minutes agoDr. Peter Marks, who oversees the FDA's vaccine division, urged the committee to consider...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 21 hours agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
Pfizer (NYSE:PFE) Trading 0.3% Higher
ETF DAILY NEWS· 7 hours agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.3% during mid-day trading on Tuesday . The company traded as high as $29.73 and last traded at $29.41. 9,834,266 shares ...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 18 hours agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 18 hours agoThe FDA approved mRESVIA based on data from a clinical trial that included more than 35,000 adults...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 1 day agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Here’s what a Nobel Prize-winning scientist wants you to know about the Covid-19 vaccines and the...
CNN via Yahoo News· 1 day agoIn his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Minneapolis-St. Paul Star Tribune· 17 hours agoGovernment advisers Wednesday said it's time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving ...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 2 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Why Things Could Get Worse for Pfizer Stock Before They Get Better | The Motley Fool
The Motley Fool· 1 day agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (PFE 0.20%) stock was a hot buy...